Adaptive Biotechnologies (ADPT) Return on Equity: 2019-2025
Historic Return on Equity for Adaptive Biotechnologies (ADPT) over the last 6 years, with Sep 2025 value amounting to -0.41%.
- Adaptive Biotechnologies' Return on Equity rose 43.00% to -0.41% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.41%, marking a year-over-year increase of 43.00%. This contributed to the annual value of -0.62% for FY2024, which is 4.00% down from last year.
- According to the latest figures from Q3 2025, Adaptive Biotechnologies' Return on Equity is -0.41%, which was up 36.74% from -0.66% recorded in Q2 2025.
- In the past 5 years, Adaptive Biotechnologies' Return on Equity registered a high of -0.21% during Q1 2021, and its lowest value of -0.84% during Q3 2024.
- Its 3-year average for Return on Equity is -0.64%, with a median of -0.67% in 2023.
- Per our database at Business Quant, Adaptive Biotechnologies' Return on Equity plummeted by 36bps in 2024 and then soared by 43bps in 2025.
- Adaptive Biotechnologies' Return on Equity (Quarterly) stood at -0.33% in 2021, then dropped by 9bps to -0.42% in 2022, then decreased by 25bps to -0.67% in 2023, then dropped by 8bps to -0.75% in 2024, then skyrocketed by 43bps to -0.41% in 2025.
- Its Return on Equity was -0.41% in Q3 2025, compared to -0.66% in Q2 2025 and -0.72% in Q1 2025.